TFS Chemicals - Aspire
Pharma Focus America
Sino Biological - Cytokine

VGXI and Resilience Establish Long-Term Partnership to Accelerate Biomanufacturing of Advanced Therapeutics

Thursday, January 25, 2024

VGXI, Inc., a prominent contract developer and manufacturer (CDMO) specializing in nucleic acid biopharmaceuticals, such as gene therapies, DNA vaccines, and RNA medicines, has recently announced a strategic multi-year partnership with National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company committed to broadening access to complex medicines.

In this novel collaboration, VGXI is set to function as the primary plasmid DNA manufacturer supporting Resilience's advanced therapy manufacturing programs. The partnership aims to leverage VGXI's ability to achieve rapid production cycles and short delivery times for a diverse range of clinical and commercial products, thereby enhancing Resilience's efficiency and overall capacity in response to the growing demand in the Cell and Gene Therapy (CGT) sector. Additionally, Resilience will gain access to VGXI's advanced analytics suite for cell banking, drug substance, and drug product.

The multi-year partnership establishes an accelerated and quality-focused network aligned with Resilience's mission of aiding researchers in the rapid, safe, and scalable development of novel therapies. Both VGXI and Resilience are enthusiastic about working together to strengthen their roles in expanding patient access to transformative medicines.

Young Park, CEO of VGXI, expressed excitement about the collaboration, stating, "We are thrilled to collaborate with Resilience, an outstanding CDMO in the cell and gene therapy space. This strategic alliance marks a milestone for both companies, emphasizing our joint commitment to addressing key supply chain challenges and accelerating the delivery of advanced therapies to patients in need."

 

Source: prnewswire.com

patheon - Mastering API production at every scaleWorld Vaccine Congress Europe 2024World Orphan Drug Congress 2024Future Labs Live USA 2024patheon - Revolutionizing PharmaHealthcare CNO SummitHealthcare CMO Summit